Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients.
Lists
Only you see this
Abstract
Intravitreal bevacizumab and ranibizumab have equivalent effects on BCVA and CRT and appeare safe over the short-term.
BibTeX
@inproceedings{li2013bevacizumab,
author = {Jun Li and Han Zhang and Peng Sun and Feng Gu and Zheli Liu},
title = {{Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients.}},
booktitle = {PubMed},
year = {2013},
doi = {10.3980/j.issn.2222-3959.2013.02.12},
}Loading related content...